NEOGENOMICS INC Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEOGENOMICS INC for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | NEO | NEOGENOMICS INC | Brown Douglas Matthew | Chief Strategy Offi ... | Option Exercise | A | 53.17 | 26,378 | 1,402,518 | 26,378 | |
| Mar 04 2021 | NEO | NEOGENOMICS INC | Brown Douglas Matthew | Chief Strategy Offi ... | Grant | A | 0.00 | 4,655 | 0 | 111,644 | 107 K to 111.6 K (+4.35 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Option Exercise | A | 53.17 | 35,171 | 1,870,042 | 35,171 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Grant | A | 0.00 | 6,207 | 0 | 13,535 | 7.3 K to 13.5 K (+84.70 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 432 | 0 | 7,328 | 7.8 K to 7.3 K (-5.57 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 169 | 0 | 7,760 | 7.9 K to 7.8 K (-2.13 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 56,423 | 0 | 2,474,716 | 2.4 M to 2.5 M (+2.33 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,158 | 0 | 2,418,293 | 2.4 M to 2.4 M (-0.09 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,339 | 0 | 2,420,451 | 2.4 M to 2.4 M (-0.10 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | A | 53.17 | 24,619 | 1,308,992 | 24,619 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Grant | A | 0.00 | 4,345 | 0 | 15,473 | 11.1 K to 15.5 K (+39.05 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 432 | 0 | 11,128 | 11.6 K to 11.1 K (-3.74 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 500 | 0 | 11,560 | 12.1 K to 11.6 K (-4.15 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 53.17 | 10,551 | 560,997 | 10,551 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Grant | A | 0.00 | 1,862 | 0 | 26,457 | 24.6 K to 26.5 K (+7.57 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 173 | 0 | 24,595 | 24.8 K to 24.6 K (-0.70 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 212 | 0 | 24,768 | 25 K to 24.8 K (-0.85 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | A | 53.17 | 24,619 | 1,308,992 | 24,619 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Grant | A | 0.00 | 4,345 | 0 | 60,643 | 56.3 K to 60.6 K (+7.72 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Payment of Exercise | F | 0.00 | 216 | 0 | 56,298 | 56.5 K to 56.3 K (-0.38 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Payment of Exercise | F | 0.00 | 212 | 0 | 56,514 | 56.7 K to 56.5 K (-0.37 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 53.17 | 38,688 | 2,057,041 | 38,688 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 6,827 | 0 | 153,747 | 146.9 K to 153.7 K (+4.65 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 608 | 0 | 146,920 | 147.5 K to 146.9 K (-0.41 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 742 | 0 | 147,528 | 148.3 K to 147.5 K (-0.50 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Option Exercise | A | 53.17 | 7,034 | 373,998 | 7,034 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Dieter Cynthia J | Chief Accounting Of ... | Grant | A | 0.00 | 1,241 | 0 | 1,846 | 605 to 1.8 K (+205.12 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | A | 53.17 | 35,171 | 1,870,042 | 35,171 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Grant | A | 0.00 | 6,207 | 0 | 377,109 | 370.9 K to 377.1 K (+1.67 %) |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | A | 53.17 | 29,895 | 1,589,517 | 29,895 | |
| Mar 03 2021 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Grant | A | 0.00 | 5,276 | 0 | 105,797 | 100.5 K to 105.8 K (+5.25 %) |